Literature DB >> 34927005

Nucleosides, Nucleotides and Nucleic Acids as Therapeutics: A Virtual Special Issue.

Amanda L Garner1.   

Abstract

Entities:  

Year:  2021        PMID： 34927005      PMCID： PMC8669708          DOI： 10.1021/acsptsci.1c00231

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN： 2575-9108


× No keyword cloud information.
  8 in total

Review 1.  The current state and future directions of RNAi-based therapeutics.

Authors:  Ryan L Setten; John J Rossi; Si-Ping Han
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

Review 2.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

Review 3.  Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.

Authors:  Peter J Thornton; Hachemi Kadri; Ageo Miccoli; Youcef Mehellou
Journal:  J Med Chem       Date:  2016-09-08       Impact factor: 7.446

Review 4.  Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.

Authors:  Jadd Shelton; Xiao Lu; Joseph A Hollenbaugh; Jong Hyun Cho; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2016-11-23       Impact factor: 60.622

Review 5.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

6.  Accelerating Translation of Innovative Drugs from Bench to Patients: ACS Pharmacology & Translational Science to Evolve, Grow, and Bridge the Gap between Chemistry and Biology in Drug Research and Development.

Authors:  Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-17

7.  Author Correction: mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

Authors:  Namit Chaudhary; Drew Weissman; Kathryn A Whitehead
Journal:  Nat Rev Drug Discov       Date:  2021-11       Impact factor: 84.694

Review 8.  The promise and challenge of therapeutic genome editing.

Authors:  Jennifer A Doudna
Journal:  Nature       Date:  2020-02-12       Impact factor: 49.962
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.